Although MHCII−/− mice with transferred polyclonal CD4+ T cells developed tumors, they had very low tumor burdens compared to mice receiving CD154-deficient or IL-2-deficient polyclonal CD4+ T cells. Here, CD4 is linked to neoplasm.